Role of Vagal Tone in Rumination Syndrome
NCT03912636 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2022-04-21
Summary
Rumination syndrome is a condition in which people repeatedly and unintentionally regurgitate undigested or partially digested food from the stomach, rechew it, and then either re-swallow it or spit it out. The mechanism of the disease is not well understood. The investigators believe that discomfort in the stomach during and immediately after meals may be an important factor for this disease. The reason for such discomfort can be due to an alteration of nervous regulation of the stomach. The investigators can study the nervous regulation that affects the stomach and other parts of the body by analysing in detail an electrocardiogram that is performed continuously for several hours. From this analysis, The investigators can study a parameter called cardiac vagal tone (CVT).
Diaphragmatic breathing (DiaB) is a respiratory exercise, in which people mainly move their abdomen to breath. DiaB is a common treatment for rumination syndrome. Patients doing DiaB can reduce the number of rumination episodes. The mechanism by which DiaB improves rumination is unknown. There is another type of breathing called slow deep breathing (SlowDB), in which people mainly breathe with their chest. SlowDB is used as a therapy for increased pain in the food pipe (oesophagus) and it might also be effective on rumination syndrome. The investigators believe that both DiaB and SlowDB can improve rumination, by modifying the nervous control of the stomach (that the investigators can monitor by measuring continuously cardiac vagal tone (CVT)). The aims of the study are to investigate the association between gastric discomfort during a meal, CVT variations (measured with the electrocardiogram during the meal) and the severity of rumination episodes. The investigators will also study how DiaB and SlowDB can modify this variable during the test. In a second step, The investigators will assess the clinical effect of respiratory exercises (DiaB and SlowDB) on the severity and frequency of regurgitations in patients diagnosed with rumination syndrome.
Method This research consists of two separate studies.
1. Study1 (to investigate the mechanism of rumination syndrome) 10 healthy volunteers and 10 rumination patients will join Study1 on 3 separate days. On each visit, the investigators will place electrocardiogram sensors and a belt that can measure the thorax or abdominal movement. All subjects will get instructions to perform SlowDB or DiaB, answer some questionnaires, eat the test meal, perform normal breathing/DiaB/SlowDB for 15 minutes, and stay quietly on the chair for 3 hours.
2. Study 2 (to assess the effect of DiaB and SlowDB on rumination syndrome) 10 patients with rumination syndrome will join Study 2. On the first visit, subjects will have the test meal, answer the symptom questionnaire 1 hour after the meal, and learn how to perform either DiaB or SlowDB. After the first visit, subjects perform DiaB or SlowDB during 15 minutes after every meal for 4 weeks. On the second visit, subjects will have the test meal, answer the symptom questionnaire 1 hour after the meal, and learn how to perform the other respiratory exercise. After a 2-week break, subjects will perform the other respiratory exercise for the next 4 weeks. On the last visit, subjects will have the test meal and answer the symptom questionnaire 1 hour after the meal.
Conditions
- Rumination
Interventions
- BEHAVIORAL
-
Diaphragmatic breathing
Subjects will perform Diaphragmatic breathing after the test meal.
- BEHAVIORAL
-
Deep Slow Breathing
Subjects will perform Deep Slow Breathing after the test meal.
- BEHAVIORAL
-
Normal breathing
Subjects will perform Normal Breathing (as a control) after the test meal as a control.
Sponsors & Collaborators
-
Queen Mary University of London
lead OTHER
Principal Investigators
-
Mays Jawad · Joint Research Management Office, Queen Mary, University of London
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-05-01
- Primary Completion
- 2020-03-31
- Completion
- 2020-03-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children
NCT03295760 ·Status: COMPLETED
-
Effects of an Integrative Health Care Model With Meditation and Care Cordination in CVS
NCT04329637 ·Status: COMPLETED ·Phase: NA
-
Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers
NCT02177890 ·Status: COMPLETED ·Phase: NA
-
Immediate Nausea and Vomiting After the Administration of Non-ionic Contrast Media
NCT03019341 ·Status: COMPLETED
-
Autonomic Reactivity and Personalized Neurostimulation
NCT06863207 ·Status: RECRUITING ·Phase: NA
-
The Effect of Bitter Taste Receptor Agonists on The Gastrointestinal Tract, Hunger and Food Intake
NCT02759926 ·Status: UNKNOWN ·Phase: NA
-
Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut Surgery
NCT01510379 ·Status: COMPLETED ·Phase: NA
-
Vestibular Dysfunction as a Cause of Chronic Nausea & Vomiting: A Follow up Survey
NCT01378351 ·Status: TERMINATED
-
The Effect of Oxytocin on Gastric Emptying
NCT01152047 ·Status: COMPLETED ·Phase: NA
-
The Effects of Ondansetron on Brain Function
NCT02460341 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating Neostigmine Effect on Reducing Gastric Residual Volume as Compared With Metoclopramide and Ondansetron
NCT05342818 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Acupuncture and Doxylamine/Pyridoxine for Moderate to Severe Nausea and Vomiting in Pregnancy
NCT04401384 ·Status: COMPLETED ·Phase: PHASE3
-
Swimming Immediately After Having a Meal
NCT05401396 ·Status: COMPLETED ·Phase: NA
-
Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers
NCT02466711 ·Status: COMPLETED ·Phase: PHASE1
-
Do Pharyngeal Packs During Orthognathic Surgery Reduce Postoperative Nausea and Vomiting
NCT02049619 ·Status: UNKNOWN ·Phase: NA
-
Applying Nutrient Drink Test in Understanding Pathophysiology of CVS
NCT03470181 ·Status: COMPLETED
-
Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion
NCT04947423 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects
NCT00332137 ·Status: COMPLETED ·Phase: PHASE2
-
Auriculotherapy and Acupuncture's Treatment for Chemotherapy-induced Nausea and Vomiting (CINV)
NCT02767791 ·Status: COMPLETED ·Phase: NA
-
Quinine and Food Intake
NCT03565133 ·Status: COMPLETED ·Phase: NA
-
Effect of Metoclopramide Versus Erythromycin on on Gastric Residual Volume
NCT04682691 ·Status: COMPLETED ·Phase: NA
-
Heartfulness Meditation (HFM) in Cyclic Vomiting Syndrome (CVS)
NCT05961995 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis
NCT01625923 ·Status: TERMINATED ·Phase: NA
-
Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness Symptoms
NCT05611814 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
NCT02357420 ·Status: COMPLETED ·Phase: PHASE2